Postoperative mediastinitis after cardiac surgery caused by Mycoplasma hominis: a case report.

Cardiovascular surgery MALDI-TOF MS Molecular identification Mycoplasma hominis Postoperative infections

Journal

Surgical case reports
ISSN: 2198-7793
Titre abrégé: Surg Case Rep
Pays: Germany
ID NLM: 101662125

Informations de publication

Date de publication:
23 Nov 2021
Historique:
received: 15 09 2021
accepted: 07 11 2021
entrez: 23 11 2021
pubmed: 24 11 2021
medline: 24 11 2021
Statut: epublish

Résumé

Mycoplasma hominis is a human commensal bacterium of the urogenital tract, and extragenital infection caused by M. hominis has rarely been reported. The identification of M. hominis is challenging, and surgeons are generally not aware that this bacteria can cause postoperative infection. Here, we report a rare case of postoperative mediastinitis caused by M. hominis after cardiac surgery in an immunocompetent patient. A 54-year-old man presented with pain and purulent discharge from the wound after aortic valve replacement and patent foramen ovale closure. However, Gram staining and culture of bacteria from the purulent discharge was negative, and empiric sulbactam/ampicillin therapy was not effective. This patient developed mediastinitis and rupture of a pseudoaneurysm of the ascending aorta caused by mediastinitis, and re-operation was performed. Then, postoperative mediastinitis caused by M. hominis or Ureaplasma species was suspected and bacterial cultures targeting these pathogens were performed. M. hominis was identified from abscess and tissue obtained from the surgical site and urine. A final diagnosis of postoperative mediastinitis caused by M. hominis was determined. The patient was initially treated with levofloxacin and then with minocycline for 3 weeks. The patient's clinical condition improved; the patient was transferred to another hospital. The role of M. hominis as a cause of postoperative infection might be underestimated in cardiac surgery. M. hominis should be considered when culture-negative purulent discharge is observed or there is no response to standard empiric treatment of postoperative infections.

Sections du résumé

BACKGROUND BACKGROUND
Mycoplasma hominis is a human commensal bacterium of the urogenital tract, and extragenital infection caused by M. hominis has rarely been reported. The identification of M. hominis is challenging, and surgeons are generally not aware that this bacteria can cause postoperative infection. Here, we report a rare case of postoperative mediastinitis caused by M. hominis after cardiac surgery in an immunocompetent patient.
CASE PRESENTATION METHODS
A 54-year-old man presented with pain and purulent discharge from the wound after aortic valve replacement and patent foramen ovale closure. However, Gram staining and culture of bacteria from the purulent discharge was negative, and empiric sulbactam/ampicillin therapy was not effective. This patient developed mediastinitis and rupture of a pseudoaneurysm of the ascending aorta caused by mediastinitis, and re-operation was performed. Then, postoperative mediastinitis caused by M. hominis or Ureaplasma species was suspected and bacterial cultures targeting these pathogens were performed. M. hominis was identified from abscess and tissue obtained from the surgical site and urine. A final diagnosis of postoperative mediastinitis caused by M. hominis was determined. The patient was initially treated with levofloxacin and then with minocycline for 3 weeks. The patient's clinical condition improved; the patient was transferred to another hospital.
CONCLUSION CONCLUSIONS
The role of M. hominis as a cause of postoperative infection might be underestimated in cardiac surgery. M. hominis should be considered when culture-negative purulent discharge is observed or there is no response to standard empiric treatment of postoperative infections.

Identifiants

pubmed: 34812956
doi: 10.1186/s40792-021-01326-0
pii: 10.1186/s40792-021-01326-0
pmc: PMC8611127
doi:

Types de publication

Journal Article

Langues

eng

Pagination

248

Informations de copyright

© 2021. The Author(s).

Références

J Thorac Cardiovasc Surg. 2005 Mar;129(3):518-24
pubmed: 15746733
Int J Infect Dis. 2014 Dec;29:166-8
pubmed: 25449252
J Antimicrob Chemother. 2012 Mar;67(3):541-50
pubmed: 22083832
J Clin Microbiol. 2013 Oct;51(10):3314-23
pubmed: 23903545
J Clin Microbiol. 1993 May;31(5):1358-61
pubmed: 7684753
Int J Infect Dis. 2015 Feb;31:53-5
pubmed: 25532483
BMC Infect Dis. 2019 Jan 14;19(1):50
pubmed: 30642271
Ann Lab Med. 2018 Jul;38(4):381-383
pubmed: 29611392
Clin Infect Dis. 2004 Feb 1;38(3):e21-4
pubmed: 14727231
Antimicrob Agents Chemother. 2020 May 21;64(6):
pubmed: 32229497
J Clin Microbiol. 2013 Jun;51(6):1834-40
pubmed: 23554198
Antimicrob Agents Chemother. 2020 Sep 21;64(10):
pubmed: 32718969
Clin Infect Dis. 2017 Oct 16;65(9):1504-1508
pubmed: 29048510
Transpl Infect Dis. 2017 Jun;19(3):
pubmed: 28294481
Int J Infect Dis. 2016 Jul;48:81-3
pubmed: 27208637
J Clin Microbiol. 2000 Mar;38(3):1175-9
pubmed: 10699016
J Antimicrob Chemother. 2018 Oct 1;73(10):2696-2703
pubmed: 29986031
JMM Case Rep. 2016 Aug 30;3(4):e005059
pubmed: 28348780
Respirology. 2011 Oct;16(7):1081-7
pubmed: 21722263
J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1845-1851
pubmed: 29924422

Auteurs

Hiroki Kitagawa (H)

Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. hkitaga@hiroshima-u.ac.jp.
Department of Infectious Diseases, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. hkitaga@hiroshima-u.ac.jp.
Project Research Center for Nosocomial Infectious Diseases, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. hkitaga@hiroshima-u.ac.jp.

Haruna Shimizu (H)

Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Keijiro Katayama (K)

Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Kayoko Tadera (K)

Project Research Center for Nosocomial Infectious Diseases, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Section of Infection Diseases Laboratory, Department of Clinical Support, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Division of Clinical Laboratory Medicine, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Toshihito Nomura (T)

Department of Infectious Diseases, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Kietaro Omori (K)

Department of Infectious Diseases, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Norifumi Shigemoto (N)

Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Department of Infectious Diseases, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Project Research Center for Nosocomial Infectious Diseases, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Translational Research Center, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Taiichi Takasaki (T)

Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Hiroki Ohge (H)

Department of Infectious Diseases, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Project Research Center for Nosocomial Infectious Diseases, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Shinya Takahashi (S)

Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Classifications MeSH